Immunosuppressive Agents: all 5,940 studies that test it
Page 47 of 60. Open to participants first (674), then studies with results posted, then the rest; newest registration first within each.
- Safety and Tolerability Study of the Helical Intravitreal Triamcinolone Implant in Diabetic Macular EdemaCompletedNCT00915837Phase 1
- A Dose Escalation Study of the Combination of Lenalidomide (Revlimid®), Dexamethasone and Cyclophosphamide in Patients Refractory or Relapsing From Stable Disease With Multiple MyelomaCompletedNCT00915408Phase 1/2
- Minimizing Immunosuppression in Old for Old Kidney TransplantationCompletedNCT00912678Phase 4
- Neoadjuvant Treatment of Docetaxel, Anthracycline and Cyclophosphamide (TAC) Versus Docetaxel and Cyclophosphamide (TC) in Triple-Negative or Her2 Positive Breast CancerTerminatedNCT00912444Phase 3
- TC Avastin. ICORG 08-10, V6CompletedNCT00911716Not applicable
- Pharmacokinetics of Tacrolimus in Liver Transplantation Patients Treated With Prograf and Modified Release TacrolimusCompletedNCT00909571Phase 3
- Combination of Continuous Low Doses of Vinorelbine, Cyclophosphamide and Interferon Alpha 2b (" Metronomic Chemotherapy ") for Antiangiogenic and Antivascular Effect. Trial With Pharmacodynamic Study in Adult Advanced NeoplasmCompletedNCT00908869Phase 1
- Triamcinolone Paste to Reduce the Incidence of Postoperative Sore ThroatCompletedNCT00908817Not applicable
- Fludarabine Phosphate, Melphalan, and Alemtuzumab Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed Hodgkin LymphomaStatus unknownNCT00907036Phase 2
- Low Dose Cyclosporin and Methotrexate Therapy in DiabetesCompletedNCT00905073Not applicable
- Calcineurin Inhibitor (CNI) Versus Steroid Cessation in Renal TransplantationStatus unknownNCT00903188Phase 4
- Her2 Chimeric Antigen Receptor Expressing T Cells in Advanced SarcomaActive, not recruitingNCT00902044Phase 1
- Tarceva/Rapamycin for Children With Low-grade Gliomas With or Without Neurofibromatosis Type 1 (NF1)CompletedNCT00901849Phase 1
- The Chinese University of Hong Kong Early Arthritis StudyCompletedNCT00901550Not applicable
- Subcutaneous Administration of Lisofylline to Healthy Normal Subjects and Subjects With Type 1 DiabetesCompletedNCT00896077Phase 1/2
- Alemtuzumab and Low-Dose Cyclosporine in Treating Patients With Severe Aplastic Anemia or Acquired Marrow FailureStatus unknownNCT00895739Phase 2
- Everolimus and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastasis From Non-Small Cell Lung CancerTerminatedNCT00892801Phase 1
- Nutritional and Contractile Regulation of Muscle GrowthCompletedNCT00891696Phase 1
- Efficacy and Safety of Human Lipoprotein Lipase (LPL)[S447X] Expressed by an Adeno-Associated Viral Vector in LPL-deficient SubjectsCompletedNCT00891306Phase 2/3
- Amrubicin + Cyclophosphamide in Advanced Solid Organ MalignanciesCompletedNCT00890955Phase 1
- Safety and Efficacy of ProHema Modulated Umbilical Cord Blood Units in Subjects With Hematologic Malignancies.CompletedNCT00890500Phase 1
- Safety Study of Calcineurin-Inhibitor-Free Immunosuppression After Liver TransplantationStatus unknownNCT00890253Phase 2
- Thalidomide and Tegafur/Uracil(UFUR) in the Treatment of Advanced Colorectal CancerStatus unknownNCT00890188Phase 2
- Study of Reduced Toxicity Myeloablative Conditioning Regimen for Cord Blood Transplantation in Pediatric AMLStatus unknownNCT00887042Phase 1/2
- Study of Reduced Toxicity Myeloablative Conditioning Regimen for Wiskott-Aldrich Syndrome (WAS)CompletedNCT00885833Phase 1/2
- Benefit of Early Protocol Biopsy and Treatment of Subclinical RejectionCompletedNCT00885820Phase 4
- N2007-02:Bevacizumab,Cyclophosphamide,& Zoledronic Acid in Patients W/ Recurrent or Refractory High-Risk NeuroblastomaCompletedNCT00885326Phase 1
- Tandem Stem Cell Transplantation for Non-Hodgkin's LymphomaActive, not recruitingNCT00882895Phase 2
- Reduced Toxicity Fludarabine (Flu) + Cyclophosphamide (CPM) + Rabbit Antithymocyte Globulin (rATG) Conditioning Regimen for Unrelated Donor Transplantation in Severe Aplastic Anemia (SAA)Status unknownNCT00882323Phase 2
- Allogeneic Stem Cell Transplantation (ALLOSCT) in Recessive Dystrophic Epidermolysis Bullosa (RDEB)TerminatedNCT00881556Early Phase 1
- Assess the Efficacy and Safety of Multi-target Therapy in Lupus NephritisCompletedNCT00876616Not applicable
- Subconjunctival Sirolimus for the Treatment of Autoimmune Active Anterior UveitiCompletedNCT00876434Phase 1
- Trial for Localised High-risk Rhabdomyosarcoma and Rhabdomyosarcoma-like Soft Tissue SarcomaCompletedNCT00876031Phase 3
- Comparison of Single Intravitreal Injection of Triamcinolone or Bevacizumab for the Treatment of Diabetic Macular EdemaCompletedNCT00874744Phase 2
- Rapamycin in Relapsed Acute Lymphoblastic LeukemiaCompletedNCT00874562Phase 1
- Trial for Patients Not Qualifying for TT4 and TT5 Protocols Because of Prior TherapyActive, not recruitingNCT00871013Phase 2
- Everolimus in Treating Patients With Relapsed or Metastatic Endometrial CancerCompletedNCT00870337Phase 2
- UARK 2008-02 A Trial for High-risk Myeloma Evaluating Accelerating and Sustaining Complete RemissionActive, not recruitingNCT00869232Phase 2
- An Open Study Assessing Bioavailability of a Modified Formulation of Tacrolimus in Kidney Transplant RecipientsCompletedNCT00865137Phase 3
- A Study of Decitabine in Combination With Escalating Doses of Rapamycin in Patients With Relapsed or Refractory Acute Myeloid LeukemiaCompletedNCT00861874Phase 1
- Comparison of ATG to Thymoglobuline in Renal TransplantationCompletedNCT00861536Phase 4
- Oral Sirolimus for In-Stent RestenosisCompletedNCT00859183Phase 4
- Radiation Therapy (IMRT) + RAD001 (Everolimus) + Cisplatin for Patients With Head and Neck CancerCompletedNCT00858663Phase 1
- Thalidomide Plus Peginterferon and Ribavirin in Patients With Interferon ResistanceStatus unknownNCT00856804Phase 2
- Safety Study of Calcineurin Inhibitor Free GvHD Prophylaxis in Allogeneic Stem Cell TransplantationStatus unknownNCT00856505Phase 1/2
- Everolimus in Treating Women With Breast Cancer That Can Be Removed by SurgeryWithdrawnNCT00855114Phase 2
- Combined Bone Marrow Transplantation (BMT) and Renal Transplant for Multiple Myeloma (MM) With End Stage Renal Disease (ESRD)CompletedNCT00854139Phase 1
- Phase I Dose-Escalation Trial of Clofarabine Followed by Escalating Doses of Fractionated Cyclophosphamide in Children With Relapsed or Refractory Acute LeukemiasTerminatedNCT00852709Phase 1
- Safety and Dosage Study of RAD001 (Everolimus) in Combination With Current Standard of Care to Treat Advanced Solid Tumors.CompletedNCT00849550Phase 1
- Azathioprine & Allopurinol in Inflammatory Bowel Disease PatientsCompletedNCT00849368Phase 1
- Augmentation of Dendritic Cell-Based Vaccines in Melanoma Patients by Depletion of Regulatory T Cells in Stage IV Melanoma PatientsCompletedNCT00847106Phase 1/2
- The GD-2008 ALL Protocol for Childhood Acute Lymphoblastic LeukemiaStatus unknownNCT00846703Phase 4
- Fludarabine Phosphate, Rituximab, and Bevacizumab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia That Has Relapsed or Not Responded To TreatmentWithdrawnNCT00845104Phase 2
- p53 Synthetic Long Peptides Vaccine With Cyclophosphamide for Ovarian CancerCompletedNCT00844506Phase 2
- Enbrel-Sulfasalazin-Early-Axial Spondyloarthritis (AS)Status unknownNCT00844142Phase 2
- A 24-Hour Pharmacokinetic Determination of BG00012 After Single-Day Oral Administration in Subjects With MSCompletedNCT00837785Phase 1
- The Safety & Efficacy of Etanercept in Psoriasis Patients Who Have Not Responded to AdalimumabCompletedNCT00833729Phase 4
- Bioequivalence of Two Tacrolimus 0.1% Topical Ointment Formulations in Patients With Atopic DermatitisCompletedNCT00833079Phase 1
- RAD001 for Non-clear Cell Renal Cell Carcinoma (RCC)CompletedNCT00830895Phase 2
- Global Study Looking at the Combination of RAD001 and Sorafenib to Treat Patients With Advanced Hepatocellular CarcinomaTerminatedNCT00828594Phase 1
- Certican® (Everolimus) Against Cytomegalovirus Disease in Renal Transplant PatientsStatus unknownNCT00828503Phase 2
- Topical Cyclosporine vs. Placebo for Epiphora Associated With DocetaxelWithdrawnNCT00824811Phase 2
- Vandetanib and Sirolimus in Patients With Recurrent GlioblastomaCompletedNCT00821080Phase 1
- CpG 7909/Montanide ISA 720 With or Without Cyclophosphamide in Combination Either With NY-ESO-1-derived Peptides or the NY-ESO-1 Protein for NY-ESO-1-expressing TumorsCompletedNCT00819806Phase 1
- RAD001 in Combination With PKC412 in Patients With Relapsed, Refractory or Poor Prognosis AML or MDSActive, not recruitingNCT00819546Phase 1
- Comparison of Extended Release Tacrolimus (Advagraf) and Cyclosporine A Microemulsion on Renal Function in Healthy VolunteersCompletedNCT00818194Phase 1
- Feasibility and Efficacy Study of Conditioning Regimen for Allogeneic Hematopoietic Cell Transplantation (HCT) With Fludarabine, Busulfan, and Total Body Irradiation (TBI)Status unknownNCT00815568Phase 2
- A Dose-Ranging Clinical Study to Assess the Safety and Efficacy of Subconjunctival Injection of Sirolimus in Patients With Dry Eye in the Controlled Adverse Environmental (CAE) ModelCompletedNCT00814944Phase 2
- Bio-availability Comparison of Three Formulations of Certolizumab Pegol in Healthy VolunteersCompletedNCT00813774Phase 1
- Pharmacokinetics of Immunosuppressive Drugs in Heart Transplant PatientsCompletedNCT00812786Phase 4
- CLL-Irl Study. CTRIAL-IE (ICORG) 07-01, V7CompletedNCT00812669Phase 2
- Calcineurin Free Immunosuppression in Renal Transplant RecipientsCompletedNCT00812123Phase 4
- Study to Compare the Safety and Efficacy of Sirolimus (Rapamune) to Tacrolimus (Advagraf) Associated to Mycophenolate Mofetil (CellCept) Between 12 and 36 Months After Kidney TransplantationTerminatedNCT00811915Phase 3
- Treatment Of Radiation Retinopathy TrialStatus unknownNCT00811200Phase 2/3
- Efficacy and Safety Study of BG00012 With Methotrexate in Patients With Active Rheumatoid ArthritisCompletedNCT00810836Phase 2
- Study of Methotrexate Efficacy Versus Cyclosporine in Moderate to Severe Atopic Dermatitis PatientsCompletedNCT00809172Phase 3
- Everolimus, Carboplatin, and Etoposide in Treating Patients With Small Cell Lung Cancer or Other Advanced Solid TumorsTerminatedNCT00807755Phase 1
- Vitiligo Treated With TL01 Combined With Tacrolimus Ointment Versus PlaceboCompletedNCT00807690Phase 3
- Fludarabine, Busulfan, and Antilymphocyte Globulin Followed by Donor Stem Cell Transplant in Treating Older Patients With Hematological CancerCompletedNCT00806767Phase 2
- Pasireotide in Combination With RAD001 in Patients With Advanced Neuroendocrine TumorsCompletedNCT00804336Phase 1
- Double-blind, Randomized, Placebo-controlled Trial of Etanercept for 12 Months in Subjects With Inclusion Body MyositisCompletedNCT00802815Early Phase 1
- Fludarabine, Busulfan, Antithymocyte Globulin, and Donor Stem Cell Transplant in Treating Patients With Multiple Myeloma That Has Not Responded to TreatmentCompletedNCT00802568Phase 2
- Leflunomide Associated With Topical Corticosteroids for Bullous PemphigoidStatus unknownNCT00802243Phase 2
- Equivalence of the Response to Vaccination of Tacrolimus Ointment to a Steroid Ointment Regimen in Children With Atopic DermatitisCompletedNCT00801957Phase 2
- Denileukine Diftitox for Relapsed ALCLWithdrawnNCT00801918Phase 2
- Intravitreal Injection Versus Sub-Tenon's Infusion of Triamcinolone Acetonide for Refractory Diabetic Macular Edema During Cataract SurgeryStatus unknownNCT00801450Phase 1/2
- Total Marrow and Total Lymph Node Irradiation, Fludarabine, and Melphalan Followed By Donor Stem Cell Transplant in Treating Patients With Advanced Hematological Cancer That Has Not Responded to TreatmentTerminatedNCT00800150Phase 1
- CERTICOEUR: A Secondary Prevention Study of Skin Cancers in Heart Transplant Patients. Everolimus Versus Calcineurin Inhibitors Multicenter TrialCompletedNCT00799188Phase 3
- The Safety and Efficacy of Etanercept (Enbrel®) for the Treatment of Discoid Lupus ErythematosusStatus unknownNCT00797784Phase 2
- Tandem High-dose Chemotherapy and Autologous Stem Cell Rescue in Patients With High-risk NeuroblastomaCompletedNCT00793845Phase 2
- Long Term Follow Up for RAD001 Therapy of Angiomyolipomata in Patients With Tuberous Sclerosis (TSC) and Sporadic Lymphangioleiomyomatosis (LAM)CompletedNCT00792766Phase 1/2
- Assessment of Safety and Pharmacokinetics of a Low Dose of Methotrexate in Healthy Adult Male Kenyan VolunteersCompletedNCT00791531Phase 1
- A Phase Ib Study of Rad001 and Sutent to Treat Renal Cell CarcinomaCompletedNCT00788060Phase 1
- Rituximab, Cladribine, and Temsirolimus in Treating Patients With Newly Diagnosed Mantle Cell LymphomaCompletedNCT00787969Phase 1
- Secondary Prophylaxis of Gastrointestinal Bleeding in Cirrhotic Patients Using THALIDOMIDEWithdrawnNCT00787436Phase 3
- A Study of the Effect of FTY720 on Pulmonary Function in Patients With Moderate AsthmaCompletedNCT00785083Phase 2
- Islet After Kidney Transplant for Type 1 DiabetesWithdrawnNCT00784966Phase 1/2
- A Multicenter Study to Compare the Efficacy and Safety of the Combination of Etanercept and Methotrexate in Treatment of Rheumatoid ArthritisWithdrawnNCT00783536Phase 4
- Aerosol Cyclosporine in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00783107Phase 1
- A Study to Evaluate Safety and Efficacy of Caelyx in Combination With Cyclophosphamide in the Treatment of Metastatic Breast Cancer (P02948)CompletedNCT00779129Phase 2